Nektar Therapeutics' (NKTR) CEO Howard Robin on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Nektar Therapeutics Inc (NKTR) President & CEO Howard W Robin Sold $3.1 million of SharesGuruFocus • 07/26/19
Nektar Therapeutics Inc (NKTR) SVP & CFO Gil M Labrucherie Sold $864,250 of SharesGuruFocus • 07/12/19
3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar TherapeuticsInvestorPlace • 06/14/19
Nektar (NKTR) Down 7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/07/19
Nektar Comes Back To ASCO 2019 More Invigorated Than Ever With Improved Melanoma DataSeeking Alpha • 06/06/19
Biotech stocks jump after drugmakers show positive data for potential breakthrough cancer treatmentsCNBC • 06/03/19